Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: borredo

That's the big question....what would be a reasonable P/E?  Ignoring market cap concerns shared by some, as I have eluded to, after settlement for big bucks and with our circumstance at that point, will we be an "average" tech company?  Major incoming money just from TPL's efforts going forward suggests we'll be anything but "average".  No risk, no debt, low OH - on the surface, it seems a P/E of 100 could be considered "reasonable".  But here I get carried away....and market cap issues arise.

SGE

Share
New Message
Please login to post a reply